[go: up one dir, main page]

AR052074A1 - Uso de una formula infantil con contenidos de proteinas reducidas - Google Patents

Uso de una formula infantil con contenidos de proteinas reducidas

Info

Publication number
AR052074A1
AR052074A1 ARP050105539A ARP050105539A AR052074A1 AR 052074 A1 AR052074 A1 AR 052074A1 AR P050105539 A ARP050105539 A AR P050105539A AR P050105539 A ARP050105539 A AR P050105539A AR 052074 A1 AR052074 A1 AR 052074A1
Authority
AR
Argentina
Prior art keywords
contents
igf
infant
reduced proteins
child formula
Prior art date
Application number
ARP050105539A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR052074(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR052074A1 publication Critical patent/AR052074A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)

Abstract

Un método para reducir continuamente el nivel circulante del factor de crecimiento tipo insulina 1(IGF-1) en los primeros meses de vida de un infante, que comprende administrar a dicho infante un composicion nutricional que contiene proteínas en una cantidad tal que la composicion contiene menos que 2,25 g de proteína por cada 100 kcal. Como se sabe que IGF-1 es un punto de control clave en la regulacion nutricional del crecimiento, esta puede ofrecer un método para producir el riesgo de desarrollar obesidad en la vida posterior.
ARP050105539A 2004-12-27 2005-12-26 Uso de una formula infantil con contenidos de proteinas reducidas AR052074A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04030371 2004-12-27

Publications (1)

Publication Number Publication Date
AR052074A1 true AR052074A1 (es) 2007-02-28

Family

ID=34927903

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105539A AR052074A1 (es) 2004-12-27 2005-12-26 Uso de una formula infantil con contenidos de proteinas reducidas

Country Status (18)

Country Link
US (2) US20100022451A1 (es)
EP (1) EP1841330B1 (es)
CN (1) CN101087539A (es)
AR (1) AR052074A1 (es)
AT (1) ATE498324T1 (es)
AU (1) AU2005321326B2 (es)
BR (1) BRPI0519507A2 (es)
CA (1) CA2593033A1 (es)
DE (1) DE602005026456D1 (es)
ES (1) ES2359573T3 (es)
MX (1) MX2007007898A (es)
MY (1) MY144008A (es)
PL (1) PL1841330T3 (es)
PT (1) PT1841330E (es)
RU (1) RU2390269C2 (es)
TW (1) TWI365045B (es)
WO (1) WO2006069918A1 (es)
ZA (1) ZA200706201B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815279B2 (en) 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
BRPI0620451A2 (pt) 2005-12-23 2011-04-12 Nutricia Nv uso de uma composição compreendendo um lipìdeo, proteìna e componente de carboidrato digerìvel
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
US8361534B2 (en) 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
CN102118976B (zh) 2008-06-13 2014-02-26 N.V.努特里奇亚 用于经剖腹产分娩的婴儿的营养组合物
US20100006459A1 (en) * 2008-07-10 2010-01-14 Ann Foley Dry cleaning bag
EP2452574A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
EP2373183A1 (en) 2008-12-08 2011-10-12 Nestec S.A. Modulation of infant fat mass
WO2010071541A1 (en) * 2008-12-17 2010-06-24 Igelösa Nutrition Science Ab Nutritional supplement with specific amino acid profile
WO2010070613A2 (en) * 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2010119088A2 (en) * 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
MY160677A (en) * 2010-12-06 2017-03-15 Nutricia Nv Fermented infant formula
EP2520181A1 (en) * 2011-05-02 2012-11-07 N.V. Nutricia Fermented infant formula
EP2514435A1 (en) 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
EP2583562A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
PL2846648T3 (pl) 2012-05-11 2016-09-30 Formuła dla niemowląt i jej otrzymywanie
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US9237761B2 (en) * 2013-02-12 2016-01-19 University Of Southern California Methods and diets for lowering glucose and/or IGF-1 levels
WO2015065194A1 (en) 2013-11-04 2015-05-07 N.V. Nutricia Fermented formula with non digestible oligosaccharides
WO2015078506A1 (en) * 2013-11-29 2015-06-04 Nestec S.A Nutritional compositions with phospholipids
RU2687038C1 (ru) 2013-11-29 2019-05-06 Нестек С.А. Соответствующие возрастным потребностям питательные композиции с различным содержанием белка
WO2015085555A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
WO2015154251A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
WO2015154256A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and,nutritional systems comprising them
WO2015154257A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and, nutritional systems comprising them
WO2015154254A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
EP3183973A1 (en) * 2015-12-22 2017-06-28 Agriculture and Food Development Authority (TEAGASC) A dairy product
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2021074374A1 (en) * 2019-10-17 2021-04-22 Société des Produits Nestlé S.A. Extensively hydrolysed infant formula
CN118415243B (zh) * 2024-07-05 2024-11-05 内蒙古伊利实业集团股份有限公司 可改善芳香族氨基酸生物利用度的营养组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2275041C2 (ru) * 1999-04-29 2006-04-27 Сосьете Де Продюи Нестле С.А. Состав молочной смеси, способ его получения и молочная смесь, содержащая его (варианты)

Also Published As

Publication number Publication date
AU2005321326A1 (en) 2006-07-06
TW200633643A (en) 2006-10-01
DE602005026456D1 (de) 2011-03-31
EP1841330B1 (en) 2011-02-16
WO2006069918A1 (en) 2006-07-06
BRPI0519507A2 (pt) 2009-03-10
ATE498324T1 (de) 2011-03-15
RU2390269C2 (ru) 2010-05-27
TWI365045B (en) 2012-06-01
EP1841330A1 (en) 2007-10-10
CA2593033A1 (en) 2006-07-06
MY144008A (en) 2011-07-29
US20110028389A1 (en) 2011-02-03
US20100022451A1 (en) 2010-01-28
ES2359573T3 (es) 2011-05-24
MX2007007898A (es) 2007-08-20
RU2007128776A (ru) 2009-02-10
ZA200706201B (en) 2008-10-29
CN101087539A (zh) 2007-12-12
PT1841330E (pt) 2011-03-14
AU2005321326B2 (en) 2011-05-26
PL1841330T3 (pl) 2011-07-29

Similar Documents

Publication Publication Date Title
AR052074A1 (es) Uso de una formula infantil con contenidos de proteinas reducidas
Reinecke Influences of the environment on the endocrine and paracrine fish growth hormone–insulin‐like growth factor‐I system
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
BRPI0410884A (pt) composição de ração para uso em um animal de estimação, e, método para o controle de peso em um animal de estimação
ES2570461T3 (es) Mejora en la promoción del crecimiento compensatorio sano
SI2571517T1 (en) Formulations of long-acting insulin
CY1119198T1 (el) ΣΤΑΘΕΡΗ ΣΥΝΘΕΣΗ ΠΟΥ ΠΕΡΙΛΑΜΒΑΝΕΙ PTHrP ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΗΣ
CL2023000087A1 (es) Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral
GT200800273A (es) Polipeptidos de factor de crecimiento de tipo insulina estabilizada
ES2392823T3 (es) Uso de compuestos de vitamina D
PE20071031A1 (es) Derivados de tiadiazolidinona como inhibidores de ptpasas
BRPI0412332A (pt) método para aumentar nìveis de antioxidante no sangue em um felino, e, composição para dieta adequada para alimentar animais de companhia jovens
BR112023013828A2 (pt) 4-cloro-n-[2-[(4-clorofenil)metil]-3-oxo-1,2,4-tiadiazol-5-il]benzamida para uso na medicina
PE20091078A1 (es) Formulacion inyectable para ocrelizumab (2h7)
BR0213740A (pt) Processos e composições para uma dieta especifica por gênero de filhotes de animais de estimação
MX2024004333A (es) Usos terapeuticos de activadores de glucoquinasa en combinacion con insulina o analogos de insulinas.
BR112017016999A2 (pt) composição, e, método de redução de concentração de amônia em um compartimento para animais.
AR044852A1 (es) Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
AR053691A1 (es) Agentes endoparasiticidas
TH80776A (th) การใช้สูตรผสมสำหรับทารกที่มีปริมาณโปรตีนลดลง
EPSTEIN Bone and mineral metabolism in hyperthyroidism
Álvarez et al. Unidades fraseológicas especializadas1
Orta Grotesque: examples in the cultural tradition of the Spanish and Russian languages
Sheikh et al. Correction: Dietary Effects of Selenium Nanoparticles on Growth Performance, Survival Rate, Chemical Composition, and Muscle Bioaccumulation of Nile Tilapia (Oreochromis niloticus)
Figueroa-Velasco et al. Niveles óptimos biológicos de lisina y treonina digestibles para cerdos en crecimiento

Legal Events

Date Code Title Description
FA Abandonment or withdrawal